Shape Therapeutics
Seattle
About Shape Therapeutics
Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $147.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2021)
- Website: shapetx.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/shape-therapeutics-15207 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.